Trial Profile
Evaluation of potential power of F-THK5351 detecting astrogliosis as a marker of neurodgeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Fluorine 18 THK 5351 (Primary)
- Indications Corticobasal degeneration; Dementia; Neurodegenerative disorders; Progressive supranuclear palsy
- Focus Diagnostic use
- 03 Oct 2018 New trial record